IN2012DN00551A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00551A
IN2012DN00551A IN551DEN2012A IN2012DN00551A IN 2012DN00551 A IN2012DN00551 A IN 2012DN00551A IN 551DEN2012 A IN551DEN2012 A IN 551DEN2012A IN 2012DN00551 A IN2012DN00551 A IN 2012DN00551A
Authority
IN
India
Prior art keywords
radioimmunoconjugate
relates
methods
radioimmvmoconjugate
hum195
Prior art date
Application number
Other languages
English (en)
Inventor
Simon Jaime
Gaylord King A
Manuel Moreno Bermudez Josue
Original Assignee
Actinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actinium Pharmaceuticals Inc filed Critical Actinium Pharmaceuticals Inc
Publication of IN2012DN00551A publication Critical patent/IN2012DN00551A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN551DEN2012 2009-07-22 2010-07-22 IN2012DN00551A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22771009P 2009-07-22 2009-07-22
PCT/US2010/042885 WO2011011592A1 (fr) 2009-07-22 2010-07-22 Procédés de génération de radioimmunoconjugués

Publications (1)

Publication Number Publication Date
IN2012DN00551A true IN2012DN00551A (fr) 2015-06-12

Family

ID=43499411

Family Applications (1)

Application Number Title Priority Date Filing Date
IN551DEN2012 IN2012DN00551A (fr) 2009-07-22 2010-07-22

Country Status (9)

Country Link
US (1) US9603954B2 (fr)
EP (1) EP2456472B1 (fr)
JP (2) JP5985392B2 (fr)
CN (2) CN102596258B (fr)
CA (1) CA2768658C (fr)
HK (1) HK1211304A1 (fr)
IN (1) IN2012DN00551A (fr)
RU (2) RU2565402C2 (fr)
WO (1) WO2011011592A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201208309D0 (en) * 2012-05-11 2012-06-27 Algeta As Complexes
US20150157742A1 (en) * 2013-12-11 2015-06-11 The European Atomic Energy Community (Euratom), Represented By The European Commission SYNTHESIS OF BIOLOGICAL COMPOUNDS LABELED WITH THE ALPHA EMITTER Ac-225
CA2949365A1 (fr) * 2014-05-16 2015-11-19 Memorial Sloan Kettering Cancer Center Marquage en une etape par actinium-225 d'anticorps pour obtenir une haute activite specifique
CA3047152A1 (fr) 2016-12-16 2018-06-21 The Australian National University Materiau radiomarque pour administration ciblee
LT3568205T (lt) 2017-01-12 2024-02-12 Radiomedix Inc. Vėžio ląstelių, per daug ekspresuojančių somatostatino receptorius, gydymas panaudojant okteotido darinius, chelatuotus su radioizotopais
WO2019027973A1 (fr) * 2017-07-31 2019-02-07 Actinium Pharmaceuticals Inc. Traitements pour une malignité hématologique
CN109550061A (zh) * 2017-09-26 2019-04-02 南京江原安迪科正电子研究发展有限公司 一种用于放射性核素标记抗体的试剂盒及应用
CA3192391A1 (fr) * 2020-09-11 2022-03-17 Actinium Pharmaceuticals, Inc. Radioimmunotherapie de la glycoproteine trophoblastique pour le traitement de cancers solides
WO2023183927A2 (fr) 2022-03-24 2023-09-28 Actinium Pharmaceuticals, Inc. Anticorps anti-cd45 humanisés
WO2023190402A1 (fr) * 2022-03-30 2023-10-05 日本メジフィジックス株式会社 Procédé de production de complexe
WO2023240135A2 (fr) 2022-06-07 2023-12-14 Actinium Pharmaceuticals, Inc. Chélateurs et conjugués bifonctionnels

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001387A (en) 1973-07-30 1977-01-04 Medi-Physics, Inc. Process for preparing radiopharmaceuticals
US4305922A (en) 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
US4296785A (en) 1979-07-09 1981-10-27 Mallinckrodt, Inc. System for generating and containerizing radioisotopes
US4454106A (en) 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4732864A (en) 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4894364A (en) 1983-10-26 1990-01-16 Greer Sheldon B Method and materials for sensitizing neoplastic tissue to radiation
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US4663129A (en) 1985-01-30 1987-05-05 The United States Of America As Represented By The United States Department Of Energy Isotopic generator for bismuth-212 and lead-212 from radium
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5306509A (en) 1987-03-17 1994-04-26 Turner Robert E Prevention and treatment of oral lesions
AU2068588A (en) 1987-08-12 1989-02-16 Immunomedics Inc. Preparation of radiolabeled conjugates
US4833329A (en) 1987-11-20 1989-05-23 Mallinckrodt, Inc. System for generating and containerizing radioisotopes
US5612016A (en) * 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
US4923985A (en) 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates
ATE134999T1 (de) 1988-05-25 1996-03-15 Us Commerce Makrocyclische chelate und verwendungsverfahren
US5292868A (en) 1989-05-26 1994-03-08 Akzo N.V. Chelating agents for attaching metal ions to proteins
WO1990015625A1 (fr) 1989-06-19 1990-12-27 Akzo N.V. RADIOIMMUNOTHERAPIE UTILISANT UNE EMISSION DE PARTICULES $g(a)
US5254328A (en) 1989-07-12 1993-10-19 Mallinckrodt Medical, Inc. Method of preparing a radiodiagnostic comprising a gaseous radionuclide, as well as a radionuclide generator suitable for using said method
US5443816A (en) 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
LU87684A1 (de) 1990-02-23 1991-10-08 Euratom Verfahren zur erzeugung von aktinium-225 und wismut-213
US5038046A (en) 1990-07-10 1991-08-06 Biotechnetics Method and generator for producing radioactive lead-212
US6403771B1 (en) 1991-02-19 2002-06-11 Actinium Pharmaceuticals, Limited Method and means for site directed therapy
CA2100709C (fr) 1992-07-27 2004-03-16 Maurits W. Geerlings Methode et moyens pour une therapie ciblee
IL113610A0 (en) * 1994-06-03 1995-08-31 Immunomedics Inc A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same
ATE473242T1 (de) 1998-05-20 2010-07-15 Immunomedics Inc Therapeutische mittel welche einen bispezifischen anti-hla class ii invariant chain x anti-pathogen antikörper enthalten
JP5064608B2 (ja) 1998-05-26 2012-10-31 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ アルファ粒子放出構成物およびその使用方法
WO1999066951A2 (fr) 1998-06-22 1999-12-29 Immunomedics, Inc. Utilisation d'anticorps bi-specifiques pour diagnostic et therapie de pre-ciblage
AU1123202A (en) 2000-09-15 2002-03-26 Sloan Kettering Inst Cancer Targeted alpha particle therapy using actinium-225 conjugates
US6670456B2 (en) 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
JP2004527528A (ja) 2001-04-09 2004-09-09 プロジェニクス・ファーマスーティカルズ・インコーポレイテッド 抗ｃｄ１９免疫毒素
US7666414B2 (en) * 2001-06-01 2010-02-23 Cornell Research Foundation, Inc. Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
WO2003055917A2 (fr) 2002-01-03 2003-07-10 Schering Aktiengesellschaft Nouvelles methodes de diagnostic et de traitement de tumeurs
US20040022726A1 (en) * 2002-06-03 2004-02-05 Goldenberg David M. Methods and compositions for intravesical therapy of bladder cancer
US20030086868A1 (en) * 2002-08-12 2003-05-08 Dangshe Ma Actinium-225 complexes and conjugates for radioimmunotherapy
US20060058218A1 (en) 2004-09-10 2006-03-16 General Electric Company Solid phase conjugation of complexing agents and targeting moieties
US7736647B2 (en) 2005-06-15 2010-06-15 Monoclonal Antibodies Therapeutics Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
EP2015775B1 (fr) 2006-05-03 2011-06-01 Bayer Schering Pharma Aktiengesellschaft Combinaison d'un anticorps l19-sip anti domaine ed-b de la fibronectine et d'un anticorps anti-egfr

Also Published As

Publication number Publication date
EP2456472B1 (fr) 2024-03-27
RU2015137512A (ru) 2018-12-25
CN104710504A (zh) 2015-06-17
CA2768658A1 (fr) 2011-01-27
EP2456472A1 (fr) 2012-05-30
RU2012106301A (ru) 2013-08-27
JP2013500258A (ja) 2013-01-07
JP2016199583A (ja) 2016-12-01
EP2456472A4 (fr) 2014-08-27
JP5985392B2 (ja) 2016-09-06
CA2768658C (fr) 2018-04-03
US20120220754A1 (en) 2012-08-30
US9603954B2 (en) 2017-03-28
EP2456472C0 (fr) 2024-03-27
CN102596258B (zh) 2015-01-28
RU2565402C2 (ru) 2015-10-20
WO2011011592A1 (fr) 2011-01-27
RU2015137512A3 (fr) 2019-04-02
CN102596258A (zh) 2012-07-18
HK1211304A1 (en) 2016-05-20
CN104710504B (zh) 2019-09-13
RU2704802C2 (ru) 2019-10-31

Similar Documents

Publication Publication Date Title
IN2012DN00551A (fr)
HK1256304A1 (zh) 用於生成單克隆抗體的方法和試劑
IL265732B (en) Easily separated bispecific antibodies with a natural immunoglobulin form
EP1940864A4 (fr) Procede de generation d'anticorps monoclonaux a region antivariable
MX353144B (es) Proteinas que contienen fc de anticuerpos heterodimericos y metodos para produccion de las mismas.
UA101487C2 (en) Humanized b-ly1 antibody formulation
NZ621170A (en) Anti-human cd52 immunoglobulins
MX2011003855A (es) Metodos para producir anticuerpos a partir de celulas plasmaticas.
ZA201004752B (en) Humanized anti-human nkg2a monoclonal antibody
SG178886A1 (en) Humanized anti-cdcp1 antibodies
PH12014501758B1 (en) Cd47 antibodies and methods of use thereof
EP2282773A4 (fr) Procédé et compositions pour préparer des anticorps et des dérivés d'anticorps avec une fucosylation centrale réduite
EP2331579A4 (fr) Anticorps monoclonaux
GB201108236D0 (en) Method
WO2009128963A3 (fr) Anticorps monoclonaux humains à neutralisation croisée dirigés contre sars-cov et procédés d'utilisation de ces derniers
DK3059337T3 (da) Adaptive immunity profiling og metoder til frembringelse af monoklonale antibodier
AP2012006262A0 (en) Monoclonal antibodies to progastrin and their uses.
EP2501722A4 (fr) Procédé de production d'anticorps monoclonaux ressemblant aux récepteurs des lymphocytes t et leurs utilisations
EP2324359A4 (fr) Anticorps monoclonal stro-4
IL193871A0 (en) Humanized anti-cd20 monoclonal antibody
HK1168871A1 (zh) 單克隆抗體
MY182178A (en) Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
WO2010121093A3 (fr) Compositions d'anticorps humanisés et procédés de liaison d'acide lysophosphatidique
NZ616382A (en) Antibodies specific to cadherin-17
WO2013115410A3 (fr) Anticorps dirigé contre la phospholipase d4